Annual Meeting of the Southern Thoracic Surgical Association. Cancun (MEX), 1996/11/07.
For many congenital heart defects, hospital mortality is no longer a sensitive parameter by which to measure outcome.
Although hospital survival rates are now excellent for a wide variety of lesions, many patients require expensive and extensive hospital-based services during the perioperative period to enable their convalescence.
These services can substantially increase the cost of care delivery.
In today's managed care environment, it would be useful if risk factors for higher cost could be identified preoperatively so that appropriate resources could be made available for the care of these patients.
The focus of this retrospective investigation is to determine if risk factors for high cost for repair of congenital heart defects can be identified.
We assessed financial risk by tracking actual hospital costs (not charges) for 144 patients undergoing repair of atrial septal defect (58 patients), ventricular septal defect (48 patients), atrioventricular canals (14 patients), or tetralogy of Fallot (24 patients) at Duke University Medical Center between July 1,1992, and September 15,1995.
Furthermore, we were able to identify where the costs occurred within the hospital.
Financial risk was defined as a large (>60% of mean costs) standard deviation, which indicated unpredictability and variability in the treatment for a group of patients.
Mots-clés Pascal : Cardiopathie, Congénital, Chirurgie correctrice, Coût, Economie santé, Traitement, Facteur risque, Homme, Appareil circulatoire pathologie, Maladie congénitale
Mots-clés Pascal anglais : Heart disease, Congenital, Corrective surgery, Costs, Health economy, Treatment, Risk factor, Human, Cardiovascular disease, Congenital disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0432384
Code Inist : 002B12A08. Création : 19/12/1997.